Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin C Wheat

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood Cancer Discovery|May 18, 2026
Rapid Transcription Dynamics Confers Cytarabine Resistance in Acute Myeloid LeukemiaGoichi Tatsumi, Rajni Kumari, Yutaro Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2019
Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulationMichael A Willcockson, Samuel J Taylor, Srikanta Ghosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2020
H1 linker histones silence repetitive elements by promoting both histone H3K9 methylation and chromatin compactionSean E Healton, Hugo D Pinto, Laxmi N Mishra, et al.
The Journal of Experimental Medicine|July 27, 2018
Tle corepressors are differentially partitioned to instruct CD8<sup>+</sup> T cell lineage choice and identityShaojun Xing, Peng Shao, Fengyin Li, et al.
Nature Genetics|September 18, 2024
Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activitySamuel J Taylor, Jacob Stauber, Oliver Bohorquez, et al.
Cancer Cell|March 5, 2021
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanismKoki Ueda, Rajni Kumari, Emily Schwenger, et al.
Science Translational Medicine|April 13, 2018
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemiaLuis A Carvajal, Daniela Ben Neriah, Adrien Senecal, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood Cancer Discovery|May 18, 2026
Rapid Transcription Dynamics Confers Cytarabine Resistance in Acute Myeloid LeukemiaGoichi Tatsumi, Rajni Kumari, Yutaro Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2019
Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulationMichael A Willcockson, Samuel J Taylor, Srikanta Ghosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2020
H1 linker histones silence repetitive elements by promoting both histone H3K9 methylation and chromatin compactionSean E Healton, Hugo D Pinto, Laxmi N Mishra, et al.
The Journal of Experimental Medicine|July 27, 2018
Tle corepressors are differentially partitioned to instruct CD8<sup>+</sup> T cell lineage choice and identityShaojun Xing, Peng Shao, Fengyin Li, et al.
Nature Genetics|September 18, 2024
Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activitySamuel J Taylor, Jacob Stauber, Oliver Bohorquez, et al.
Cancer Cell|March 5, 2021
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanismKoki Ueda, Rajni Kumari, Emily Schwenger, et al.
Science Translational Medicine|April 13, 2018
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemiaLuis A Carvajal, Daniela Ben Neriah, Adrien Senecal, et al.
Pageof 2